Zynerba Pharmaceuticals Aktie
WKN DE: A14XCV / ISIN: US98986X1090
07.08.2017 20:22:58
|
Zynerba Pharmaceuticals Remains Sharply Lower After Initial Sell-Off
(RTTNews) - After falling sharply at the start of trading, shares of Zynerba Pharmaceuticals (ZYNE) continue to see substantial weakness in afternoon trading on Monday. Zynerba is currently down by 58.3 percent after hitting its lowest intraday level in over a year.
The initial sell-off by Zynerba came after the drug developer said its synthetic cannabis-based gel to treat epilepsy failed a mid-stage study.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Zynerba Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |